STERIS plc
NYSE:STE

Watchlist Manager
STERIS plc Logo
STERIS plc
NYSE:STE
Watchlist
Price: 208.68 USD 0.33% Market Closed
Market Cap: 20.6B USD
Have any thoughts about
STERIS plc?
Write Note

STERIS plc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

STERIS plc
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
STERIS plc
NYSE:STE
Interest Income Expense
-$114.3m
CAGR 3-Years
-25%
CAGR 5-Years
-24%
CAGR 10-Years
-19%
Medtronic PLC
NYSE:MDT
Interest Income Expense
-$585m
CAGR 3-Years
-21%
CAGR 5-Years
2%
CAGR 10-Years
-15%
Trinity Biotech PLC
NASDAQ:TRIB
Interest Income Expense
-$7m
CAGR 3-Years
-2%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
No Stocks Found

STERIS plc
Glance View

Market Cap
20.6B USD
Industry
Health Care

Emerging as a silent pioneer in the intricate world of sterilization and infection prevention, STERIS plc has carved out a significant niche in the healthcare industry. Originally founded in 1985, the company has grown through strategic acquisitions and organic expansion. It primarily focuses on protecting patients by ensuring high standards of cleanliness and safety in healthcare environments. STERIS offers a broad array of products and services, from sophisticated sterilization equipment for hospital operating rooms to surface disinfectants and washes that keep healthcare facilities safe and clean. Their diverse portfolio ensures that they can meet the evolving needs of the global healthcare sector, which increasingly demands stringent infection control protocols. What sets STERIS apart is its innovative approach to both service and product offerings, which blend together to create comprehensive infection prevention solutions. By marrying state-of-the-art technology with a service-oriented business model, the company supports hospitals, medical-device companies, and research labs by maintaining their operational readiness and compliance with health standards. Revenue is generated through a mix of product sales as well as renewable service contracts, which guarantee recurring income. These long-term service agreements, alongside the consistent demand for advanced sterilization solutions, have enabled STERIS to sustain and even enhance its financial health while supporting the mission of safer patient care globally.

STE Intrinsic Value
220.38 USD
Undervaluation 5%
Intrinsic Value
Price

See Also

What is STERIS plc's Interest Income Expense?
Interest Income Expense
-114.3m USD

Based on the financial report for Sep 30, 2024, STERIS plc's Interest Income Expense amounts to -114.3m USD.

What is STERIS plc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-19%

Over the last year, the Interest Income Expense growth was 10%. The average annual Interest Income Expense growth rates for STERIS plc have been -25% over the past three years , -24% over the past five years , and -19% over the past ten years .

Back to Top